According to the Centers for Medicare and Medicaid Services, national healthcare expenses were more than 17% of U.S. GDP in 2019. Looking forward, these expenditures are projected to grow at an CAGR of 5.4% through 2028 to reach $6.2 trillion. By then, healthcare expenses are anticipated to account for roughly 20% of the entire economic output.

As a citizen this number is troubling, as an investor it shows opportunity. There are several options for investors looking to cash in on the growth of the healthcare market.

Wearable Health Solutions (OTCMKTS: WHSI) recently announced the launch date for its highly-anticipated iHelp MAX 4G cellular PERS device. Sold directly through WHSI's network of dealers and distributors, the iHelp MAX 4G will be available to customers in June of 2022.

The much-lauded emergency medical device will include such improved features as:

· 	Fall Detection,
· 	Geo-Fencing,
· 	AI Utilizing Google Assistant and Alexa,
· 	Notifications, Daily Check-Ins, and Medication Reminders

WHSI's commitment to this device has been covered in the media and is expected to bring success to WHSI as it provides calm and comfort to its customers. With an ever-growing market of independent senior citizens and lone workers, the need for WHSI's iHelp MAX 4G product is at an all-time high.

Dealer Portal Allows for Easy, Intuitive Data Transmission

With the knowledge of its growing market, WHSI has made it easier than ever for customers to find its products through its dealer network. WHSI's dealers are able to take advantage of the industry-wide competitive advantage WHSI's new dealer portal provides. In its 2021 acquisition of mHealthCentral's assets and its technology, WHSI created additional layers of support, utility, and competition for its iHelp MAX 4G PERS device.

The back-end-as-a-service (BAAS) allows for intuitive methods of data transmission from the PERS devices and retransmits that data to the appropriate parties (subscribers, monitoring centers, healthcare providers, Front-End Portal & User Interfaces, and API controllers). Ease of transmission between parties is paramount for WHSI to compete in the growing PERS marketplace.

Making data easier to transmit improves the user experience, provides greater insight into health, and provides for greater security and more accurate and speedy response time in case of an emergency.

Worldwide Business with kathy ireland® Boosts Exposure

WHSI has been selected to appear on Worldwide Business with kathy ireland® to discuss their Next Generation Medical Alert Technology.

In a concerted effort to get its product in front of its customer base, WHSI was interviewed by modeling legend and business icon Kathy Ireland in February 2022.. WHSI's appearance on the show will air later this year - stay tuned for updates. This appearance will help in driving leads within the wearable health market to WHSI's network of distributors and dealers.

Through Ireland's broadcast network, WHSI could potentially find itself in front of more than 200 million potential customers. Carried on Fox Business Network and Bloomberg International Television as branded content, and with video available on social media outlets, Worldwide Business with kathy ireland® is creating compelling video content for WHSI's iHelp MAX 4G PERS product.

Bausch Health Cos Inc (NYSE:BHC): The Bausch Health Cos Inc stock could be one to watch closely for investors who may be interested in healthcare stocks at this point in time. The company was actually in the news earlier this week on Tuesday when it announced that it was going to cut down on its debts by as much as $200 million. The company announced that it was going to pay down that entire amount on senior loans on March 31 through the cash generated from its operations. In this context, it is perhaps necessary to note, that Bausch, which had previously been known as Valeant had a debt pile of a staggering $22.7 billion back on December 31, 2021, as per publicly available data.

Becton Dickinson and Co (NYSE:BDX) Multinational medical technology firm BD is one of the companies that could come into sharp focus among investors over the course of the coming days. The company was in the news yesterday after it made an announcement with regards to the pricing terms and the earlier offers that it had received from Morgan Stanley & Co LLC regarding the cash tender offers.

The maximum tender payment for the same has been set at $200,000,000 and the tenders are being submitted in accordance with the offer of purchase that had been dated March 16, 2022. It remains to be seen if the latest developments can actually lead to a move in the stock over the course of the coming days.

DexCom (NASDAQ:DXCM): The third stock to make up this list is of DexCom. The company is best known for having made a massive difference in the lives of people who suffer from diabetes. In 2006, the company had been responsible for launching the world's first continuous glucose monitoring system and had managed to bring about a revolution in this particular field.

The stock has performed strongly over the course of the past year and managed to clock gains of as much as 38% during the period. Over the past five years, the stock has run up gains of a staggering 482% and that is perhaps another reason why it may be a good idea to track the DexCom stock.

Senseonics Holdings Inc (NYSEAMERICAN:SENS): In the fourth quarter, total revenue grew slightly to $4.0 million compared to $3.9 million for the fourth quarter of 2020. Net income stood at $84.4 million, or 19 cents a share, compared to a net loss of $101.6 million, or 41 cents a share in a year-ago quarter.

Global net revenue for the full year 2022 is expected to be in the range of $14.0 million - $18.0 million.

Masimo Corporation (NASDAQ:MASI) will be in focus as the company reported preliminary fourth-quarter results late Wednesday.

The medical technology company said quarterly sales would fall short due to component shortages and other supply-chain woes.

The company projected $285 million - $315 million in product revenue for the quarter that ends April 2, missing the $328 million analyst consensus.

"In prior quarters, we were able to weather the storm of Covid-related supply chain issues," Chief Executive Joe Kiani said in a statement, adding that had the company been able to ship what was ordered, revenue would have exceeded expectations. The company, he said, expects to be able to fulfill open orders through the rest of the year, backing its full-year forecast of $1.35 billion in product revenue.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. Capital Gains Report 'CGR' is responsible for the production and distribution of this content. CGR is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. CGR authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. CGR has been compensated three thousand dollars via wire transfer by Wearable Health Solutions, Inc. to produce and syndicate content for WHSI. As part of that content, readers, subscribers, and website viewers, are expected to read the full disclaimers and financial disclosures statement that can be found on our website.

CONTACT: To educate and attract more investors contact us at:

Mark McKelvie

mark@capitalgainsreport.com

(754) 233-0966

.

(C) 2022 M2 COMMUNICATIONS, source M2 PressWIRE